These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 32649919)

  • 1. Circulating tumour cells as a potential biomarker for lung cancer screening: a prospective cohort study.
    Marquette CH; Boutros J; Benzaquen J; Ferreira M; Pastre J; Pison C; Padovani B; Bettayeb F; Fallet V; Guibert N; Basille D; Ilie M; Hofman V; Hofman P;
    Lancet Respir Med; 2020 Jul; 8(7):709-716. PubMed ID: 32649919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating tumour cells as a potential screening tool for lung cancer (the AIR study): protocol of a prospective multicentre cohort study in France.
    Leroy S; Benzaquen J; Mazzetta A; Marchand-Adam S; Padovani B; Israel-Biet D; Pison C; Chanez P; Cadranel J; Mazières J; Jounieaux V; Cohen C; Hofman V; Ilie M; Hofman P; Marquette CH;
    BMJ Open; 2017 Dec; 7(12):e018884. PubMed ID: 29282271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral arterial disease and systematic detection of circulating tumor cells: rationale and design of the DETECTOR prospective cohort study.
    Yannoutsos A; Fontaine M; Galloula A; Damotte D; Chatellier G; Paterlini-Bréchot P; Meyer G; Pastre J; Duchatelle V; Marini V; Schwering KL; Lazareth I; Ghaffari P; Stansal A; Sanson H; Labrousse C; Beaussier H; Nasr NB; Zins M; Salmeron S; Messas E; Lajonchère JP; Emmerich J; Priollet P; Trédaniel J
    BMC Cardiovasc Disord; 2019 Sep; 19(1):212. PubMed ID: 31519196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study.
    Tammemagi MC; Schmidt H; Martel S; McWilliams A; Goffin JR; Johnston MR; Nicholas G; Tremblay A; Bhatia R; Liu G; Soghrati K; Yasufuku K; Hwang DM; Laberge F; Gingras M; Pasian S; Couture C; Mayo JR; Nasute Fauerbach PV; Atkar-Khattra S; Peacock SJ; Cressman S; Ionescu D; English JC; Finley RJ; Yee J; Puksa S; Stewart L; Tsai S; Haider E; Boylan C; Cutz JC; Manos D; Xu Z; Goss GD; Seely JM; Amjadi K; Sekhon HS; Burrowes P; MacEachern P; Urbanski S; Sin DD; Tan WC; Leighl NB; Shepherd FA; Evans WK; Tsao MS; Lam S;
    Lancet Oncol; 2017 Nov; 18(11):1523-1531. PubMed ID: 29055736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose CT screening among never-smokers with or without a family history of lung cancer in Taiwan: a prospective cohort study.
    Chang GC; Chiu CH; Yu CJ; Chang YC; Chang YH; Hsu KH; Wu YC; Chen CY; Hsu HH; Wu MT; Yang CT; Chong IW; Lin YC; Hsia TC; Lin MC; Su WC; Lin CB; Lee KY; Wei YF; Lan GY; Chan WP; Wang KL; Wu MH; Tsai HH; Chian CF; Lai RS; Shih JY; Wang CL; Hsu JS; Chen KC; Chen CK; Hsia JY; Peng CK; Tang EK; Hsu CL; Chou TY; Shen WC; Tsai YH; Tsai CM; Chen YM; Lee YC; Chen HY; Yu SL; Chen CJ; Wan YL; Hsiung CA; Yang PC;
    Lancet Respir Med; 2024 Feb; 12(2):141-152. PubMed ID: 38042167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers.
    Horeweg N; Scholten ET; de Jong PA; van der Aalst CM; Weenink C; Lammers JW; Nackaerts K; Vliegenthart R; ten Haaf K; Yousaf-Khan UA; Heuvelmans MA; Thunnissen E; Oudkerk M; Mali W; de Koning HJ
    Lancet Oncol; 2014 Nov; 15(12):1342-50. PubMed ID: 25282284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating tumor cell clusters are a potential biomarker for detection of non-small cell lung cancer.
    Manjunath Y; Upparahalli SV; Suvilesh KN; Avella DM; Kimchi ET; Staveley-O'Carroll KF; Li G; Kaifi JT
    Lung Cancer; 2019 Aug; 134():147-150. PubMed ID: 31319973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial.
    Patz EF; Greco E; Gatsonis C; Pinsky P; Kramer BS; Aberle DR
    Lancet Oncol; 2016 May; 17(5):590-9. PubMed ID: 27009070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung cancer screening by low-dose CT scan in France: final results of the DEP KP80 study after three rounds.
    Leleu O; Storme N; Basille D; Auquier M; Petigny V; Berna P; Letierce A; Couraud S; de Bermont J; Milleron B; Jounieaux V
    EBioMedicine; 2024 Nov; 109():105396. PubMed ID: 39396424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison Between Radiological Semantic Features and Lung-RADS in Predicting Malignancy of Screen-Detected Lung Nodules in the National Lung Screening Trial.
    Li Q; Balagurunathan Y; Liu Y; Qi J; Schabath MB; Ye Z; Gillies RJ
    Clin Lung Cancer; 2018 Mar; 19(2):148-156.e3. PubMed ID: 29137847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Sentinel" circulating tumor cells allow early diagnosis of lung cancer in patients with chronic obstructive pulmonary disease.
    Ilie M; Hofman V; Long-Mira E; Selva E; Vignaud JM; Padovani B; Mouroux J; Marquette CH; Hofman P
    PLoS One; 2014; 9(10):e111597. PubMed ID: 25360587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating Tumor-Macrophage Fusion Cells and Circulating Tumor Cells Complement Non-Small-Cell Lung Cancer Screening in Patients With Suspicious Lung-RADS 4 Nodules.
    Manjunath Y; Suvilesh KN; Mitchem JB; Avella Patino DM; Kimchi ET; Staveley-O'Carroll KF; Pantel K; Yi H; Li G; Harris PK; Chaudhuri AA; Kaifi JT
    JCO Precis Oncol; 2022 Mar; 6():e2100378. PubMed ID: 35417204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of direct referral for fast CT scan in early lung cancer detection in general practice. A clinical, cluster-randomised trial.
    Guldbrandt LM
    Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches.
    Krebs MG; Hou JM; Sloane R; Lancashire L; Priest L; Nonaka D; Ward TH; Backen A; Clack G; Hughes A; Ranson M; Blackhall FH; Dive C
    J Thorac Oncol; 2012 Feb; 7(2):306-15. PubMed ID: 22173704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial.
    Walter JE; Heuvelmans MA; de Jong PA; Vliegenthart R; van Ooijen PMA; Peters RB; Ten Haaf K; Yousaf-Khan U; van der Aalst CM; de Bock GH; Mali W; Groen HJM; de Koning HJ; Oudkerk M
    Lancet Oncol; 2016 Jul; 17(7):907-916. PubMed ID: 27283862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Lung Cancer Risk Among Persons Undergoing Screening or Guideline-Concordant Monitoring of Lung Nodules in the Mississippi Delta.
    Osarogiagbon RU; Liao W; Faris NR; Fehnel C; Goss J; Shepherd CJ; Qureshi T; Matthews AT; Smeltzer MP; Pinsky PF
    JAMA Netw Open; 2023 Feb; 6(2):e230787. PubMed ID: 36848089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung cancer screening using low-dose computed tomography in at-risk individuals: the Toronto experience.
    Menezes RJ; Roberts HC; Paul NS; McGregor M; Chung TB; Patsios D; Weisbrod G; Herman S; Pereira A; McGregor A; Dong Z; Sitartchouk I; Boerner S; Tsao MS; Keshavjee S; Shepherd FA
    Lung Cancer; 2010 Feb; 67(2):177-83. PubMed ID: 19427055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of lung cancer screening with low-dose CT in Gejiu, Yunnan: A population-based, screening cohort study.
    Wei MN; Su Z; Wang JN; Gonzalez Mendez MJ; Yu XY; Liang H; Zhou QH; Fan YG; Qiao YL
    Thorac Cancer; 2020 May; 11(5):1224-1232. PubMed ID: 32196998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR).
    Blanchon T; Bréchot JM; Grenier PA; Ferretti GR; Lemarié E; Milleron B; Chagué D; Laurent F; Martinet Y; Beigelman-Aubry C; Blanchon F; Revel MP; Friard S; Rémy-Jardin M; Vasile M; Santelmo N; Lecalier A; Lefébure P; Moro-Sibilot D; Breton JL; Carette MF; Brambilla C; Fournel F; Kieffer A; Frija G; Flahault A;
    Lung Cancer; 2007 Oct; 58(1):50-8. PubMed ID: 17624475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Smokers Health Multiple ACtions (SMAC-1) Trial: Study Design and Results of the Baseline Round.
    Antonicelli A; Muriana P; Favaro G; Mangiameli G; Lanza E; Profili M; Bianchi F; Fina E; Ferrante G; Ghislandi S; Pistillo D; Finocchiaro G; Condorelli G; Lembo R; Novellis P; Dieci E; De Santis S; Veronesi G
    Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.